Their results indicated that miR-373 functions as an oncogene, thus confirming its significance as a biomarker for both breast cancer diagnosis and prognosis, particularly due to its targeting of VEGF and cyclin D1 (62). This evidence concerns the gene VEGFA and breast cancer.